Nature Publishing Group

SHERPA: Yellow

People

  1. Reuter
    Reuter
  2. Ladanyi
    Ladanyi
  3. Al-Ahmadie
    Al-Ahmadie
  4. Fine
    Fine
  5. Gopalan
    Gopalan
  6. Tickoo
    Tickoo
  7. Antonescu
    Antonescu
  8. Shia
    Shia
  9. Chen
    Chen
  10. Weigelt
    Weigelt

Groups

  1. GSK Faculty (2503)
  2. Department of Medicine (2046)
  3. Department of Pathology and Laboratory Medicine (1930)
  4. Sloan Kettering Institute Faculty (1425)
  5. Sloan Kettering Institute Postdocs (1261)
  6. Center for Hematologic Malignancies (1096)
  7. Hematologic Malignancies, Division of (1002)
  8. Solid Tumor Oncology Division (990)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (966)
  10. Tow Center for Developmental Oncology (TCDO) (891)
Search Within
Formats
  1. Journal Article (3656)
  2. Meeting Abstract (2162)
  3. Review (191)
  4. Editorial (105)
  5. Research Letter (96)
  6. Correspondence (32)
  7. Conference Paper (23)
  8. Guidelines (13)
  9. Miscellaneous (9)
Groups
  1. GSK Faculty (2503)
  2. Department of Medicine (2046)
  3. Department of Pathology and Laboratory Medicine (1930)
  4. Sloan Kettering Institute Faculty (1425)
  5. Sloan Kettering Institute Postdocs (1261)
  6. Center for Hematologic Malignancies (1096)

More Groups

People
  1. Victor Reuter (297)
  2. Marc Ladanyi (225)
  3. Hikmat Al-Ahmadie (197)
  4. David Klimstra (195)
  5. Robert Soslow (165)
  6. Samson Fine (159)

More People

Years
  1. 2025 (327)
  2. 2024 (365)
  3. 2023 (326)
  4. 2022 (355)
  5. 2021 (316)
  6. 2020 (375)

More Years

Publications
  1. Laboratory Investigation (1890)
  2. Nature (604)
  3. Nature Communications (453)
  4. Bone Marrow Transplantation (381)
  5. Leukemia (283)
  6. Nature Medicine (249)

More Publications

Results (6287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: A survey on behalf of the ALWP of the EBMT
    Meeting Abstract

    Nagler, A.; Labopin, M.; Polge, E.; Esteve, J.; Bazarbachi, A.; Brissot, E.; Bug, G.; Ciceri, F.; Giebel, S.; Gilleece, M.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Optimizing lentiviral vector transduction to gene modify cord blood CD8(+) T cells for off-the-shelf adoptive cell therapy to treat cancer
    Meeting Abstract

    Lo Presti, V.; Dunnebach, E.; Plantinga, M.; Cornel, A.; Kuball, J.; Boelens, J. J.; van Til, N.; Nierkens, S.
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Combining clofarabine and fludarabine with exposure targeted busulfan for pediatric leukemia: An effective, low toxic, TBI-free conditioning regimen
    Meeting Abstract

    Versluys, A. B.; de Koning, C.; Bierings, M.; Nierkens, S.; Lindemans, C.; Bresters, D.; Kollen, W.; Lankester, A.; Boelens, J. J.
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • A prospective cohort study comparing long-term outcomes with and without palifermin in patients receiving hematopoietic cell transplantation for hematologic malignancies
    Meeting Abstract

    Saber, W.; Steinert, P.; Zhang, M. J.; Chen, M.; Pope, A.; Keating, A.; Wingard, J.; Ballen, K.; Stiff, P.; Perales, M. A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Pharmacokinetics of melphalan in lymphoma patients undergoing beam and autologous hematopoietic stem cell transplant
    Meeting Abstract

    Dahi, P.; Lin, A.; Flynn, J.; Uruburo, C.; Mcgeary, I.; Schofield, R.; Bhatt, V.; Derespiris, L.; Figgins, B.; Griffin, M.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Two year analysis of a prospective phase I/II clinical trial in adults using TCR alpha/beta depleted stem cell transplantation from matched related and unrelated donors
    Meeting Abstract

    de Witte, M. A.; Janssen, A.; Nijssen, C. A.; van Rhenen, A.; Admiraal, R.; van der Wagen, L.; Minnema, M. C.; Petersen, E.; Raymakers, R. A. P.; Westinga, K.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells
    Meeting Abstract

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Implications of novel risks scores (AML-DRG and AML-HCT-CR) in allogeneic CD34+ selected graft transplant outcomes
    Meeting Abstract

    Trillo, R. A.; Recio, M. G.; Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of allogeneic hematopoietic stem cell transplant in patients with cerebral adrenoleukodystrophy vary by donor cell source, conditioning regimen, and stage of cerebral disease status
    Meeting Abstract

    Boelens, J. J.; Chiesa, R.; Duncan, C.; Jones, S.; Kapoor, N.; Kuhl, J. S.; Lindemans, C.; Prasad, V. K.; Sevin, C.; Shamir, E.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • CMV seropositivity drives T cell reconstitution after CD34-selected allogeneic HCT despite reduction of viremia with letermovir
    Meeting Abstract

    Cho, C.; Lavery, J.; Ruiz, J.; Maloy, M.; Maslak, P.; Giralt, S. A.; O'Reilly, R. J.; van den Brink, M. R. M.; Perales, M. A.
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save